How an Indian Government Policy Backfired: Prescription Drug Price

The JM Buzz

How an Indian Government Policy Backfired: Prescription Drug Price Regulations Led to More Marketing for Unregulated Medications

Listen now

Description

A new Journal of Marketing study shows how India aimed to make essential medicines more affordable but inadvertently ended up reducing drug sales. Read an in-depth recap of this research here: https://www.ama.org/2024/06/04/how-an-indian-government-policy-backfired-prescription-drug-price-regulations-led-to-more-marketing-for-unregulated-medications/ Read the full Journal of Marketing article here: https://doi.org/10.1177/00222429241242685 Reference: Saravana Jaikumar, Pradeep K. Chintagunta, and Arvind Sahay, “Do No Harm? Unintended Consequences of Pharmaceutical Price Regulation in India,” Journal of Marketing. Narrator: Adalgisa Butkewitsch Acknowledgments: Sushma Kambagowni Topics: regulations, drug prices, healthcare marketing The JM Buzz Podcast is a production of the American Marketing Association's Journal of Marketing and is produced by ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠University FM

More Episodes

See all »

The JM Buzz

Published 11/07/24

Do Good and Talk About It! How Financial Valuation and External Reporting of Marketing Assets Benefits Companies

Do you know the financial value of Gatorade's or Netflix’s customer base? If your answer is no, you're not alone. Firms provide little external information about the financial value of their marketing assets such as brands and customer relationships. This Journal of Marketing study shows that...

Published 10/24/24

The Boeing Lesson: Laws That Prevent Frivolous Litigation Also Reduce the Likelihood of Product Recalls

What happens when legal changes aimed to prevent frivolous lawsuits make it more difficult for shareholders to hold managers accountable? This Journal of Marketing study documents the unintended consequence of firms becoming less likely to recall products. Read an in-depth recap of this...

Published 10/17/24